Liječenje Langerhansove histiocitoze u djece (CROSBI ID 201498)
Prilog u časopisu | stručni rad
Podaci o odgovornosti
Bilić, Ernest ; Bojanić, Katarina ; Dapić, Tomislav ; Femenić, Ranka ; Husar, Karmela ; Konja, Josip ; Murat-Susić, slobodna ; Pavlović, Maja ; Potocki, Kristina ; Antabak, Anko ; Anticević, Darko ; Rajić, Ljubica
hrvatski
Liječenje Langerhansove histiocitoze u djece
Langerhans' cell histiocytosis (LCH) is a disease characterised by pathologic accumulation and proliferation of histiocytes, cells from the monocyte-macrophage system, in various tissues and organs. In this retrospective study we analyzed patients charts treated in the Department of pediatric hematology and oncology at the University Hospital Zagreb with the diagnosis of LCH. Twenty-two children were diagnosed between January 1st 1996 and December 31st 2010, and all were treated with chemotherapy. 19 patients survived (86%) and the remaining 3 (14%), all under the age of 2 with multisystem disease, died. At the time of diagnosis 12 children (55%) presented with single-system disease, the most common were bone lesions in 8 children (36%). All children were treated according to protocols LCH-I and LCH -III. Eight children had mild complications of treatment and the disease itself. Diabetes insipidus remains in 4 children.
histiocitoza kod djece
nije evidentirano
engleski
Treatment of langerhans cell histiocytosis in children
nije evidentirano
histiocytosis in children
nije evidentirano